Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|December 30, 2022
The off-label uses of pipeline embolization device for complex cerebral aneurysms: Mid-term follow-up in a single centerHuachen Zhang, Jiyang Ren, Jiangdian Wang, et al.Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|May 10, 2016
Constructing Structure Ensembles of Intrinsically Disordered Proteins from Chemical Shift DataHuichao Gong, Sai Zhang, Jiangdian Wang, et al.Clinical Therapeutics|December 4, 2014
Pharmacokinetic interaction of finasteride with tamsulosin hydrochloride: an open-label, randomized, 3-period crossover study in healthy Chinese male volunteersNannan Chu, Hongrong Xu, Guoqin Wang, et al.Archives of Pathology & Laboratory Medicine|July 21, 2018
Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric CancerKarina Kulangara, Nancy Zhang, Ellie Corigliano, et al.Clinical Pharmacology : Advances and Applications|February 28, 2020
A Single- and Multiple-Dose Study to Evaluate the Pharmacokinetics of Fixed-Dose Grazoprevir/Elbasvir in Healthy Chinese ParticipantsHaiyan Li, Zhenhua Yang, Shuang Zhang, et al.Clinical Therapeutics|May 5, 2018
A Phase I, Single- and Multiple-dose Study to Evaluate the Pharmacokinetics of Elbasvir and Grazoprevir in Healthy Chinese ParticipantsTommy Tsang Cheung, Joanne Wing Yan Chiu, Man Fung Yuen, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 27, 2019
Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 studyYung-Jue Bang, Yoon-Koo Kang, Daniel V Catenacci, et al.JAMA Oncology|March 16, 2018
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 TrialCharles S Fuchs, Toshihiko Doi, Raymond W Jang, et al.Pageof 1